作者: Monica Boirivant
DOI: 10.1016/B978-0-12-415847-4.00079-3
关键词:
摘要: In the last 20 years, studies of models mucosal inflammation have greatly contributed to knowledge main immunological features inflammatory bowel disease (IBD), role bacterial microflora on pathogenesis, and predict efficacy new treatments disease. this chapter, we describe some representative experimental IBD basis their contribution unraveling pathogenetic pathways operating in human IBD, with particular focus similarities use preclinical therapeutic approaches diseases.